ELV logo

Elevance Health, Inc. (ELV) Cash From Operations

Annual CFO:

$5.81B-$2.25B(-27.95%)
December 31, 2024

Summary

  • As of today, ELV annual cash from operations is $5.81 billion, with the most recent change of -$2.25 billion (-27.95%) on December 31, 2024.
  • During the last 3 years, ELV annual cash from operations has fallen by -$2.56 billion (-30.56%).
  • ELV annual cash from operations is now -45.66% below its all-time high of $10.69 billion, reached on December 31, 2020.

Performance

ELV Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVcash flow metrics

Quarterly CFO:

$1.14B-$919.00M(-44.74%)
September 30, 2025

Summary

  • As of today, ELV quarterly cash from operations is $1.14 billion, with the most recent change of -$919.00 million (-44.74%) on September 30, 2025.
  • Over the past year, ELV quarterly cash from operations has dropped by -$1.54 billion (-57.60%).
  • ELV quarterly cash from operations is now -82.45% below its all-time high of $6.47 billion, reached on March 31, 2023.

Performance

ELV Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVcash flow metrics

TTM CFO:

$4.91B-$1.54B(-23.89%)
September 30, 2025

Summary

  • As of today, ELV TTM cash from operations is $4.91 billion, with the most recent change of -$1.54 billion (-23.89%) on September 30, 2025.
  • Over the past year, ELV TTM cash from operations has increased by +$2.78 billion (+130.50%).
  • ELV TTM cash from operations is now -60.15% below its all-time high of $12.33 billion, reached on March 31, 2023.

Performance

ELV TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

ELV Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-27.9%-57.6%+130.5%
3Y3 Years-30.6%-77.0%-57.6%
5Y5 Years-4.2%+198.7%-40.1%

ELV Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-30.9%at low-82.5%+138.2%-60.1%+137.6%
5Y5-Year-45.7%at low-82.5%+138.2%-60.1%+137.6%
All-TimeAll-Time-45.7%+4744.0%-82.5%+138.2%-60.1%+2651.8%

ELV Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
$1.14B(-44.7%)
$4.91B(-23.9%)
Jun 2025
-
$2.05B(+102.0%)
$6.45B(+33.2%)
Mar 2025
-
$1.02B(+44.1%)
$4.85B(-16.5%)
Dec 2024
$5.81B(-27.9%)
$706.00M(-73.6%)
$5.81B(+172.5%)
Sep 2024
-
$2.68B(+498.9%)
$2.13B(+3.1%)
Jun 2024
-
$447.00M(-77.4%)
$2.07B(-42.1%)
Mar 2024
-
$1.98B(+166.6%)
$3.57B(-55.7%)
Dec 2023
$8.06B(-4.0%)
-$2.97B(-213.7%)
$8.06B(-15.3%)
Sep 2023
-
$2.61B(+34.0%)
$9.51B(-19.5%)
Jun 2023
-
$1.95B(-69.9%)
$11.82B(-4.1%)
Mar 2023
-
$6.47B(+526.2%)
$12.33B(+46.8%)
Dec 2022
$8.40B(+0.4%)
-$1.52B(-130.8%)
$8.40B(-27.5%)
Sep 2022
-
$4.92B(+100.8%)
$11.59B(+26.4%)
Jun 2022
-
$2.45B(-3.5%)
$9.17B(+9.2%)
Mar 2022
-
$2.54B(+52.0%)
$8.40B(+0.4%)
Dec 2021
$8.36B(-21.7%)
$1.67B(-33.2%)
$8.36B(-20.4%)
Sep 2021
-
$2.50B(+48.8%)
$10.51B(+53.3%)
Jun 2021
-
$1.68B(-32.8%)
$6.85B(-35.8%)
Mar 2021
-
$2.50B(-34.3%)
$10.68B(-0.1%)
Dec 2020
$10.69B(+76.3%)
$3.81B(+431.6%)
$10.69B(+30.3%)
Sep 2020
-
-$1.15B(-120.9%)
$8.20B(-25.6%)
Jun 2020
-
$5.51B(+119.1%)
$11.02B(+58.6%)
Mar 2020
-
$2.52B(+89.5%)
$6.95B(+14.6%)
Dec 2019
$6.06B(+58.4%)
$1.33B(-20.4%)
$6.06B(+16.6%)
Sep 2019
-
$1.67B(+16.0%)
$5.20B(+25.6%)
Jun 2019
-
$1.44B(-11.8%)
$4.14B(+27.6%)
Mar 2019
-
$1.63B(+252.1%)
$3.24B(-15.3%)
Dec 2018
$3.83B(-8.5%)
$463.00M(-23.7%)
$3.83B(+85.5%)
Sep 2018
-
$606.90M(+11.9%)
$2.06B(-46.6%)
Jun 2018
-
$542.20M(-75.5%)
$3.86B(+4.0%)
Mar 2018
-
$2.21B(+270.2%)
$3.71B(-11.3%)
Dec 2017
$4.18B(+30.6%)
-$1.30B(-154.1%)
$4.18B(-27.4%)
Sep 2017
-
$2.40B(+511.7%)
$5.76B(+33.4%)
Jun 2017
-
$393.10M(-85.4%)
$4.32B(-5.9%)
Mar 2017
-
$2.69B(+878.6%)
$4.59B(+43.2%)
Dec 2016
$3.20B(-22.0%)
$274.70M(-71.5%)
$3.20B(-17.5%)
Sep 2016
-
$963.50M(+45.5%)
$3.88B(+19.6%)
Jun 2016
-
$662.00M(-49.2%)
$3.25B(-13.5%)
Mar 2016
-
$1.30B(+36.6%)
$3.75B(-8.7%)
Dec 2015
$4.11B(+21.2%)
$954.90M(+191.4%)
$4.11B(+18.6%)
Sep 2015
-
$327.70M(-71.9%)
$3.46B(-7.3%)
Jun 2015
-
$1.17B(-29.7%)
$3.74B(+2.4%)
Mar 2015
-
$1.66B(+437.1%)
$3.65B(+7.6%)
Dec 2014
$3.39B(+10.5%)
$309.20M(-48.4%)
$3.39B(+0.6%)
Sep 2014
-
$599.70M(-44.5%)
$3.37B(-18.9%)
Jun 2014
-
$1.08B(-23.0%)
$4.16B(+18.7%)
Mar 2014
-
$1.40B(+384.2%)
$3.50B(+14.2%)
Dec 2013
$3.07B(+11.8%)
$289.60M(-79.1%)
$3.07B(-13.3%)
Sep 2013
-
$1.39B(+225.5%)
$3.54B(+47.9%)
Jun 2013
-
$426.00M(-55.9%)
$2.39B(-3.8%)
Mar 2013
-
$965.10M(+27.0%)
$2.49B(-9.4%)
DateAnnualQuarterlyTTM
Dec 2012
$2.74B(-18.7%)
$759.80M(+216.3%)
$2.74B(+34.4%)
Sep 2012
-
$240.20M(-53.9%)
$2.04B(-36.8%)
Jun 2012
-
$521.50M(-57.4%)
$3.23B(-7.2%)
Mar 2012
-
$1.22B(+2012.4%)
$3.48B(+3.2%)
Dec 2011
$3.37B(+138.2%)
$57.90M(-96.0%)
$3.37B(-13.6%)
Sep 2011
-
$1.43B(+85.3%)
$3.90B(+15.8%)
Jun 2011
-
$771.80M(-30.8%)
$3.37B(+18.1%)
Mar 2011
-
$1.11B(+89.9%)
$2.85B(+101.5%)
Dec 2010
$1.42B(-53.4%)
$587.00M(-34.5%)
$1.42B(+64.8%)
Sep 2010
-
$896.50M(+250.1%)
$859.40M(-38.7%)
Jun 2010
-
$256.10M(+179.3%)
$1.40B(-8.0%)
Mar 2010
-
-$322.90M(-1187.2%)
$1.52B(-49.9%)
Dec 2009
$3.04B(+19.9%)
$29.70M(-97.9%)
$3.04B(-13.3%)
Sep 2009
-
$1.44B(+281.3%)
$3.51B(+18.5%)
Jun 2009
-
$377.60M(-68.3%)
$2.96B(+9.9%)
Mar 2009
-
$1.19B(+139.7%)
$2.69B(+6.2%)
Dec 2008
$2.54B(-41.6%)
$497.30M(-44.3%)
$2.54B(-19.3%)
Sep 2008
-
$892.80M(+700.7%)
$3.14B(+12.9%)
Jun 2008
-
$111.50M(-89.2%)
$2.78B(-18.1%)
Mar 2008
-
$1.03B(-6.4%)
$3.40B(-21.8%)
Dec 2007
$4.34B(+7.4%)
$1.10B(+107.1%)
$4.34B(-7.0%)
Sep 2007
-
$533.30M(-26.5%)
$4.67B(-1.7%)
Jun 2007
-
$725.90M(-63.4%)
$4.75B(+12.4%)
Mar 2007
-
$1.98B(+38.5%)
$4.23B(+4.5%)
Dec 2006
$4.04B(+24.2%)
$1.43B(+132.8%)
$4.04B(+13.1%)
Sep 2006
-
$614.70M(+205.8%)
$3.58B(-8.1%)
Jun 2006
-
$201.00M(-88.8%)
$3.89B(-10.4%)
Mar 2006
-
$1.80B(+86.5%)
$4.34B(+33.4%)
Dec 2005
$3.26B(+149.9%)
$963.80M(+3.8%)
$3.26B(+11.8%)
Sep 2005
-
$928.30M(+41.9%)
$2.91B(+21.7%)
Jun 2005
-
$654.10M(-7.9%)
$2.39B(+40.4%)
Mar 2005
-
$710.50M(+14.5%)
$1.71B(+30.9%)
Dec 2004
$1.30B(+14.0%)
$620.50M(+51.5%)
$1.30B(+18.4%)
Sep 2004
-
$409.60M(+1290.7%)
$1.10B(+7.6%)
Jun 2004
-
-$34.40M(-111.2%)
$1.02B(-14.9%)
Mar 2004
-
$307.50M(-26.4%)
$1.20B(+5.1%)
Dec 2003
$1.14B(+15.4%)
$417.70M(+26.0%)
$1.14B(+4.6%)
Sep 2003
-
$331.50M(+128.3%)
$1.09B(-4.3%)
Jun 2003
-
$145.20M(-41.7%)
$1.14B(+8.1%)
Mar 2003
-
$249.00M(-32.2%)
$1.06B(+6.6%)
Dec 2002
$991.10M(+51.4%)
$367.20M(-3.5%)
$991.10M(+29.3%)
Sep 2002
-
$380.50M(+533.1%)
$766.70M(+20.4%)
Jun 2002
-
$60.10M(-67.2%)
$636.90M(-3.4%)
Mar 2002
-
$183.30M(+28.4%)
$659.40M(+0.7%)
Dec 2001
$654.60M(-4.4%)
$142.80M(-43.0%)
$654.60M(+27.9%)
Sep 2001
-
$250.70M(+203.5%)
$511.80M(+96.0%)
Jun 2001
-
$82.60M(-53.7%)
$261.10M(+46.3%)
Mar 2001
-
$178.50M
$178.50M
Dec 2000
$684.50M(+211.4%)
-
-
Dec 1999
$219.80M(+83.3%)
-
-
Dec 1998
$119.90M
-
-

FAQ

  • What is Elevance Health, Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for Elevance Health, Inc.?
  • What is Elevance Health, Inc. annual cash from operations year-on-year change?
  • What is Elevance Health, Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Elevance Health, Inc.?
  • What is Elevance Health, Inc. quarterly cash from operations year-on-year change?
  • What is Elevance Health, Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for Elevance Health, Inc.?
  • What is Elevance Health, Inc. TTM cash from operations year-on-year change?

What is Elevance Health, Inc. annual cash from operations?

The current annual cash from operations of ELV is $5.81B

What is the all-time high annual cash from operations for Elevance Health, Inc.?

Elevance Health, Inc. all-time high annual cash from operations is $10.69B

What is Elevance Health, Inc. annual cash from operations year-on-year change?

Over the past year, ELV annual cash from operations has changed by -$2.25B (-27.95%)

What is Elevance Health, Inc. quarterly cash from operations?

The current quarterly cash from operations of ELV is $1.14B

What is the all-time high quarterly cash from operations for Elevance Health, Inc.?

Elevance Health, Inc. all-time high quarterly cash from operations is $6.47B

What is Elevance Health, Inc. quarterly cash from operations year-on-year change?

Over the past year, ELV quarterly cash from operations has changed by -$1.54B (-57.60%)

What is Elevance Health, Inc. TTM cash from operations?

The current TTM cash from operations of ELV is $4.91B

What is the all-time high TTM cash from operations for Elevance Health, Inc.?

Elevance Health, Inc. all-time high TTM cash from operations is $12.33B

What is Elevance Health, Inc. TTM cash from operations year-on-year change?

Over the past year, ELV TTM cash from operations has changed by +$2.78B (+130.50%)
On this page